How high is the success rate of bone marrow transplantation for MDS?
The success rate of bone marrow transplantation for MDS may exceed 80%, but the specific outcome depends on individual circumstances.
MDS, also known as myelodysplastic syndrome, is a malignant tumor within the hematologic system. Bone marrow transplantation is the only potentially curative treatment for MDS, with a cure rate typically exceeding 80%. However, due to differences in individual conditions, actual outcomes may vary. If a patient has good overall health and strong recovery ability after treatment, the success rate tends to be higher. Conversely, if complications occur post-treatment or the patient's hematopoietic function is inherently poor, the success rate may decrease accordingly.
When treating MDS, patients are categorized into lower-risk and higher-risk groups based on their disease status. Lower-risk patients can benefit from supportive therapies that alleviate symptoms such as anemia and fatigue caused by MDS, thereby improving quality of life. Higher-risk patients have a greater likelihood of progressing to leukemia and require timely hematopoietic stem cell transplantation.
In addition, during bone marrow transplantation, patients must follow medical guidance regarding medication use to minimize graft-versus-host disease and other rejection reactions.